Cardiovascular Safety, Long‐Term Noncardiovascular Safety, and Efficacy of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systemic Review and Meta‐Analysis With Trial Sequential Analysis

Cardiovascular Safety, Long‐Term Noncardiovascular Safety, and Efficacy of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systemic Review and Meta‐Analysis With Trial Sequential Analysis

BackgroundThe cardiovascular and long‐term noncardiovascular safety and efficacy of SGLT2 (sodium–glucose cotransporter 2) inhibitors have not been well documented. Methods and ResultsFor cardiovascular outcomes, we performed a meta‐analysis with trial sequential analysis of randomized controlled tr...

Full description

Bibliographic Details
Main Authors: Xin‐Lin Zhang, Qing‐Qing Zhu, Yu‐Han Chen, Xue‐Ling Li, Fu Chen, Jian‐An Huang, Biao Xu
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
cardiovascular disease
meta‐analysis
observational study
randomized controlled trial
SGLT2 (sodium–glucose cotransporter 2) inhibitor
trial sequential analysis
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.117.007165

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.117.007165

Similar Items